INS and fatty liver disease: Reduced hepatic steatosis along with increased hepatic insulin sensitivity and fatty acid oxidation can promote apolipoprotein B degradation, thereby contributing to lowering the secretion of LDL and LDL particle and circulating cholesterol level [3].